EUVIMEDEUVIMED entdecken
Crossref

Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy

Wenlu Hu, Yanxia Ding, Kelei Guan, Panpan Zhang, Jingbo Su, Chunyi Zhang, Wei Li, Chaofeng Lian, Qihua Yang, Shengyun Liu, Tianfang Li

Clinical Rheumatology · 2024

DOI: 10.1007/s10067-024-06982-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Wenlu Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Chitinase-3-Like Protein 1, Antibodies, Monoclonal, Humanized, Methotrexate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Science and Technology Innovation Talents in Universities of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidChitinase-3-Like Protein 1Antibodies, Monoclonal, HumanizedMethotrexateAntirheumatic AgentsHumansMaleFemaleMiddle AgedAdultDrug Therapy, CombinationTriglyceridesBody Mass IndexCholesterol, HDLAgedCholesterolChinaEast Asian People

Stichwörter der Autor:innen

Metabolic parametersRheumatoid arthritisSerum YKL-40Tocilizumab

Substanzen

tocilizumabChitinase-3-Like Protein 1Antibodies, Monoclonal, HumanizedCHI3L1 protein, humanMethotrexateAntirheumatic AgentsTriglyceridesCholesterol, HDLCholesterol

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. tfli@zzu.edu.cn.

Förderung

  • Science and Technology Innovation Talents in Universities of Henan Province

Zitieren

APA

Hu, W., Ding, Y., Guan, K., Zhang, P., Su, J., Zhang, C., Li, W., Lian, C., Yang, Q., Liu, S., & Li, T. (2024). Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-06982-9

Vancouver

Hu W, Ding Y, Guan K, Zhang P, Su J, Zhang C, et al. Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-06982-9

BibTeX
@article{Hu2024,
  author = {Hu, Wenlu and Ding, Yanxia and Guan, Kelei and Zhang, Panpan and Su, Jingbo and Zhang, Chunyi and Li, Wei and Lian, Chaofeng and Yang, Qihua and Liu, Shengyun and Li, Tianfang},
  title = {Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy},
  journal = {Clinical Rheumatology},
  year = {2024},
  doi = {10.1007/s10067-024-06982-9}
}
Kostenlos starten →